A pH-Sensitive Prodrug Nanocarrier Based on Diosgenin for Doxorubicin Delivery to Efficiently Inhibit Tumor Metastasis

BACKGROUND: The metastasis, one of the biggest barriers in cancer therapy, is the leading cause of tumor deterioration and recurrence. The anti.-metastasis has been considered as a feasible strategy for clinical cancer management. It is well known that diosgenin could inhibit tumor metastasis and do...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zeliang, Wang, Haibo, Xin, Guang, Zeng, Zhi, Li, Shiyi, Ming, Yue, Zhang, Xiaoyu, Xing, Zhihua, Li, Li, Li, Youping, Zhang, Boli, Zhang, Junhua, Niu, Hai, Huang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480473/
https://www.ncbi.nlm.nih.gov/pubmed/32943867
http://dx.doi.org/10.2147/IJN.S250549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480473/
https://www.ncbi.nlm.nih.gov/pubmed/32943867
http://dx.doi.org/10.2147/IJN.S250549

Ejemplares similares